-
Services
Featured Specialties
-
Locations
Location Type
-
Patients & Visitors
Sandip Mukherjee, MD, and Jaime Gerber, MD, lead the Executive Health Program care team of renowned physician specialists and administrative staff. They are available to answer any questions about the program.
Sandip Mukherjee, MD, is a cardiologist at Yale Medicine who specializes in treating and preventing conditions such as hypertension and aortic aneurysms. Dr. Mukherjee’s focus is on identifying risk factors of coronary artery disease, one of the most common causes of heart attack. In addition to seeing patients, Dr. Mukherjee conducts clinical research to investigate safer and more effective ways of treating heart diseases. Dr. Mukherjee is an associate professor of medicine at Yale School of Medicine.
Jaime Gerber, MD, subspecializes in preventive cardiology and diagnoses and treats a range of conditions including coronary artery disease, high cholesterol, and peripheral vascular disease. He directs the Yale New Haven Heart and Vascular Center laboratory for vascular ultrasound testing for peripheral arterial disease and consults on complex cardiology cases that involve coronary artery disease, peripheral artery disease, and risk factor modification. Dr. Gerber is an associate professor of clinical medicine at Yale School of Medicine.
Mehra Golshan, MD, MBA, is a cancer surgeon and a leader in breast cancer care on a national and international level. In addition to caring for Yale Medicine patients, he serves as Deputy Chief Medical Officer for Surgical Services and Clinical Director of the Breast Cancer Program for the Yale Cancer Center, Smilow Cancer Hospital, and Executive Vice Chair in the Department of Surgery. He is responsible for coordinating and expanding cancer surgery services throughout Yale New Haven Health and the Smilow network. Dr. Golshan’s approach to breast cancer treatment is through a specialized team approach. For each new patient, Smilow brings together a team of medical oncologists, radiation oncologists, reconstruction surgeons, pathologists, genetics, breast imagers, radiologists, program nurses, and a robust clinical research program.
David Hafler, MD, is a world-renowned expert on multiple sclerosis (MS) and chair of the Department of Neurology, where he has presided over a major expansion in the last several years. A professor of neurology and of immunobiology at Yale School of Medicine, Dr. Hafler is also a prolific researcher whose work has led to major advances in the understanding and treatment of MS, including identification of it as an autoimmune and genetic disease. He leads a lab at Yale that conducts cutting-edge research into MS and develops new treatments.
Elena Ratner, MD, is a gynecologic oncologist specializing in ovarian malignancies. An advocate for cancer survivors, she is also co-founder and director of the Yale Medicine Sexual, Intimacy and Menopause Program (SIMS), one of the first programs in the country to focus on supporting cancer survivors coping with issues that may not be discussed in the other clinical settings. Dr. Ratner is a professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine. Her clinical research focuses on new targeted drugs for ovarian cancer that will provide truly personalized care, and on reversing chemotherapy resistance in ovarian and uterine cancers. She also studies chemotherapy targeted drug development, quality-of-life programs for patients and early cancer detection. Dr. Ratner is a recipient of multiple awards, including the 2015 Yale Cancer Center Award for Clinical Excellence.
Jonathan Siner, MD, is the clinical section chief of Pulmonary, Critical Care and Sleep Medicine, and specializes in quality and safety work and treating interstitial lung disease (ILD), or diseases that cause lung scarring. He is the chair of the Yale New Haven Health System Intensive Care Unit (ICU) Committee and medical director of the Tele-ICU. He recently completed 11 years directing the Yale New Haven Hospital (YNHH) Medical Intensive Care Unit (MICU). Dr. Siner’s research interests include low-tidal volume ventilation for ARDS (acute respiratory distress syndrome), and he practices in the ambulatory arena seeing patients with Interstitial Lung Disease. In 2019, Dr. Siner received Yale Medicine’s Excellence in Quality and Safety Award.
